Maxwellbiomedical

Kardium

This company develops a mapping and pulsed field ablation system used by physicians to treat patients with atrial fibrillation.

ChamberTech

The company develops a hybrid ablation catheter system to treat patients with persistent atrial fibrillation by targeting both endocardial and epicardial heart surfaces.

Acesion Pharma ApS

This biotech company develops small-molecule drugs to treat atrial fibrillation by inhibiting ion channels for patients with cardiac arrhythmia.

Affera

This medical technology company develops integrated cardiac mapping and ablation systems for electrophysiologists to treat patients suffering from heart rhythm disorders.

EP Solutions SA

This company develops non-invasive cardiac mapping technology to assist physicians in diagnosing rhythm disturbances and improving outcomes for heart failure patients.

Epix Therapeutics

This company develops temperature-controlled cardiac ablation systems for clinicians to treat patients suffering from heart rhythm disorders such as atrial fibrillation.

AtaCor Medical

This company develops extravascular defibrillation leads and deployment systems for cardiac patients to manage heart rhythms without entering the vascular system.

S4 Medical

This company develops an esophageal deviation device to protect patients from thermal injury during cardiac ablation procedures for atrial fibrillation.